Abstract
Multisystem inflammatory syndrome in children (MIS-C) is a known complication of COVID-19. There is still limited knowledge about this condition. Here, we report the case of a previously healthy toddler boy, who presented with acute liver failure and duodenal lesions resulting in severe haematemesis and haemorrhagic shock, requiring intensive care unit care. The patient had persistent transaminitis, a deranged coagulation profile, inflammatory markers were elevated, and laboratory tests were negative for common infectious hepatitis aetiologies as well as COVID-19 Reverse transcription polymerase chain reaction. His COVID-19 antibody was reactive. Upper gastrointestinal endoscopy revealed a Forrest grade III duodenal ulcer. Looking into the constellation of symptoms and laboratory findings a confirmed diagnosis of acute viral hepatitis caused by MIS-C was made. Hence, he was given intravenous methylprednisolone along with intravenous immunoglobulins, after which he improved clinically and transaminitis resolved. The patient was discharged on clinical improvement and was doing fine on follow-up up to 6 months.
Reference17 articles.
1. Center for disease control and prevention, center for preparedness and response: Multisystem inflammatory syndrome in children (MIS-C) associated with Coronavirus disease 2019 (COVID-19), clinician outreach and communication (COCA) Webinar. Available: https://emergency.cdc.gov/coca/calls/2020/callinfo_051920.asp?deliveryName=USCDC_1052-DM28623 [Accessed 19 May 2020].
2. Multisystem Inflammatory Syndrome in Children in New York State
3. Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19 Geneva: World Health Organization, Available: https://www.who.int/news-room/commentaries/detail/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19 [Accessed 19 May 2023].
4. EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure
5. Frequency of hepatobiliary manifestations and concomitant liver disease in inflammatory bowel disease patients;Silva;Biomed Res Int,2019